Clinical trial
D-Serine Monotherapy for Schizophrenia
NCT00215917 · Herzog Hospital, Other · Unknown status
Key facts
| NCT number | NCT00215917 |
|---|---|
| Title | D-Serine Monotherapy for Schizophrenia |
| Lead sponsor | Herzog Hospital, Other |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | D-serine 2100 mg daily |
| Enrollment | 40 |
| First posted | Sep 22, 2005 |
| Last update posted | May 3, 2006 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: